Clinical Trial Update: Phase Ib/II Study of Primary Chemotherapy With Paclitaxel, Gemcitabine, and Sunitinib [Phase 1, Phase 2]

View source ↗

Summary

A Phase Ib/II clinical trial evaluating primary chemotherapy with paclitaxel, gemcitabine, and sunitinib in breast cancer has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Breast Cancer

Drugs mentioned

• Gemcitabine (Gemzar) (gemcitabine)
• Paclitaxel (Taxol) (paclitaxel)
• Sunitinib (Sutent) (sunitinib)

Snippet

Sponsor: Jungsil Ro | Conditions: Breast Cancer | Phase 1, Phase 2 | Status: COMPLETED